Species difference of metabolic clearance of bisphenol A using cryopreserved hepatocytes from rats, monkeys and humans

Toxicology Letters

Volumn 198, Issue 2, 2010, Pages 210-215

  Kurebayashi, Hideo ^a   Okudaira, Kazuho ^b   Ohno, Yasuo ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Bisphenol A; Cryopreserved hepatocytes; Hepatic clearance; Human; Monkey; Rat

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; GLUCURONIDE; SULFATE;

ANIMAL CELL; ARTICLE; CRYOPRESERVATION; FEMALE; GLUCURONIDATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MALE; METABOLIC RATE; METABOLISM; METABOLITE; MONKEY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; SULFATION; TOXICOKINETICS;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYOPRESERVATION; GLUCURONIDES; HEPATOCYTES; HUMANS; MACACA FASCICULARIS; MALE; METABOLIC CLEARANCE RATE; MOLECULAR STRUCTURE; PHENOLS; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

RATTUS;

EID: 77955923099     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.06.017     Document Type: Article

References (29)

1. Ashby J., Tinwell H. Uterotrophic activity of bisphenol A in the immature rat. Environ. Health Perspect. 1998, 106:719-720.
2. Davies B., Morris T. Physiological parameters in laboratory animals and humans. Pharm. Res. 1993, 10:1093-1095.
3. Elsby R., Maggs J.L., Ashby J., Park B.K. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J. Pharmacol. Exp. Ther. 2001, 297:103-113.
4. Guyomard C., Rialland L., Fremond B., Chesne C., Guillouzo A. Influence of alginate gel entrapment and cryopreservation on survival and xenobiotic metabolism capacity of rat hepatocytes. Toxicol. Appl. Pharmacol. 1996, 141:349-356.
5. Hammond A.H., Garle M.J., Fry J.R. A preliminary comparison of LiverBeadsTM with a conventional rat hepatocyte culture preparation: some aspects of xenobiotic metabolism and related toxicity. ATLA 1999, 27:111-119.
6. Inoue H., Yokota H., Makino T., Yuasa A., Kato S. Bisphenol A glucuronide, a major metabolite in rat bile after liver perfusion. Drug Metab. Dispos. 2001, 29:1084-1087.
7. Iwatsubo T., Suzuki H., Sugiyama Y. Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data. J. Pharmacol. Exp. Ther. 1997, 283:462-469.
8. Ito K., Houston J.B. Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Pharm. Res. 2004, 21:785-792.
9. Iyanagi T. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification. Int. Rev. Cytol. 2007, 260:35-112.
10. Knaak J.B., Sullivan L.J. Metabolism of bisphenol A in the rat. Toxicol. Appl. Pharmacol. 1966, 8:175-184.
11. Kuester R.K., Sipes I.G. Prediction of metabolic clearance of bisphenol A (4,4'-dihydroxy-2,2-diphenylpropane) using cryopreserved human hepatocytes. Drug Metab. Dispos. 2007, 35:1910-1915.
12. Kurebayashi H., Harada R., Stewart R.K., Numata H., Ohno Y. Disposition of a low dose of bisphenol a in male and female cynomolgus monkeys. Toxicol. Sci. 2002, 68:32-42.
13. Kurebayashi H., Betsui H., Ohno Y. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide. Toxicol. Sci. 2003, 73:17-25.
14. Laws S.C., Carey S.A., Ferrell J.M., Bodman G.J., Cooper R.L. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol. Sci. 2000, 54:154-167.
15. Matthews J.B., Twomey K., Zacharewski T.R. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem. Res. Toxicol. 2001, 14:149-157.
16. McGinnity D.F., Soars M.G., Urbanowicz R.A., Riley R.J. Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. Drug Metab. Dispos. 2004, 32:1247-1253.
17. Nakagawa Y., Tayama S. Metabolism and cytotoxicity of bisphenol A and other bisphenols in isolated rat hepatocytes. Arch. Toxicol. 2000, 74:99-105.
18. Negishi T., Tominaga T., Ishii Y., Kyuwa S., Hayasaka I., Kuroda Y., Yoshikawa Y. Comparative study on toxicokinetics of bisphenol A in F344 rats, monkeys (Macaca fascicularis), and chimpanzees (Pan troglodytes). Exp. Anim. 2004, 53:391-394.
19. Obach R.S. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab. Dispos. 1999, 27:1350-1359.
20. Pritchett J.J., Kuester R.K., Sipes I.G. Metabolism of bisphenol a in primary cultured hepatocytes from mice, rats, and humans. Drug Metab. Dispos. 2002, 30:1180-1185.
21. Pottenger L.H., Domoradzki J.Y., Markham D.A., Hansen S.C., Cagen S.Z., Waechter J.M. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol. Sci. 2000, 54:3-18.
22. Radominska-Pandya A., Czernik P.J., Little J.M., Battaglia E., Mackenzie P.I. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab. Rev. 1999, 31:817-899.
23. Riley R.J., McGinnity D.F., Austin R.P. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes. Drug Metab. Dispos. 2005, 33:1304-1311.
24. Snyder R.W., Maness S.C., Gaido K.W., Welsch F., Sumner S.C., Fennell T.R. Metabolism and disposition of bisphenol A in female rats. Toxicol. Appl. Pharmacol. 2000, 168:225-234.
25. Soars M.G., Burchell B., Riley R.J. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. J. Pharmacol. Exp. Ther. 2002, 301:382-390.
26. Teeguarden J.G., Waechter, Clewell H.J., Covington T.R., Barton H.A. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol. Sci. 2005, 85:823-838.
27. Tominaga T., Negishi T., Hirooka H., Miyachi A., Inoue A., Hayasaka I., Yoshikawa Y. Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC-MS/MS method. Toxicology 2006, 226:208-217.
28. Upmeier A., Degen G.H., Diel P., Michna H., Bolt H.M. Toxicokinetics of bisphenol A in female DA/Han rats after a single i.v. and oral administration. Arch. Toxicol. 2000, 74:431-436.
29. Völkel W., Colnot T., Csanády G.A., Filser J.G., Dekant W. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem. Res. Toxicol. 2002, 15:1281-1287.